Recurrent portopulmonary hypertension after liver transplantation: Management with epoprostenol and resolution after retransplantation

We report a case of portopulmonary hypertension in which the pulmonary hypertension resolved after initial orthotopic liver transplantation. Portopulmonary hypertension recurred when the transplanted liver failed and again resolved after a second liver transplantation. Intravenous epoprostenol was a...

Full description

Saved in:
Bibliographic Details
Published in:Liver transplantation 2001-07, Vol.7 (7), p.645-648
Main Authors: Kett, Daniel H., Acosta, Rita C., Campos, Michael A., Rodriguez, Miguel J., Quartin, Andrew A., Schein, Roland M.H.
Format: Article
Language:English
Subjects:
Antihypertensive Agents - therapeutic use
Epoprostenol - therapeutic use
Hemodynamics
Humans
Hypertension, Portal - drug therapy
Hypertension, Portal - etiology
Hypertension, Portal - physiopathology
Hypertension, Portal - therapy
Hypertension, Pulmonary - drug therapy
Hypertension, Pulmonary - etiology
Hypertension, Pulmonary - physiopathology
Hypertension, Pulmonary - therapy
Liver Transplantation - adverse effects
Male
Middle Aged
Recurrence
Reoperation
Treatment Failure
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report a case of portopulmonary hypertension in which the pulmonary hypertension resolved after initial orthotopic liver transplantation. Portopulmonary hypertension recurred when the transplanted liver failed and again resolved after a second liver transplantation. Intravenous epoprostenol was administered perioperatively to control the pulmonary hypertension in both instances. ( Liver Transpl 2001;7:645-648.)
ISSN:1527-6465
1527-6473
DOI:10.1053/jlts.2001.25358